Harpreet Singh‐Jasuja

6.2k total citations
30 papers, 2.4k citations indexed

About

Harpreet Singh‐Jasuja is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Harpreet Singh‐Jasuja has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 20 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Harpreet Singh‐Jasuja's work include Immunotherapy and Immune Responses (25 papers), Cancer Immunotherapy and Biomarkers (9 papers) and vaccines and immunoinformatics approaches (8 papers). Harpreet Singh‐Jasuja is often cited by papers focused on Immunotherapy and Immune Responses (25 papers), Cancer Immunotherapy and Biomarkers (9 papers) and vaccines and immunoinformatics approaches (8 papers). Harpreet Singh‐Jasuja collaborates with scholars based in Germany, United Kingdom and Switzerland. Harpreet Singh‐Jasuja's co-authors include Hans‐Georg Rammensee, Norbert Hilf, Hansjörg Schild, René E. M. Toes, Danièle Arnold-Schild, Hans Ulrich Scherer, Steffen Walter, Hans-Georg Rammensee, Toni Weinschenk and Hermann Wagner and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Harpreet Singh‐Jasuja

28 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harpreet Singh‐Jasuja Germany	20	1.7k	1.1k	687	283	213	30	2.4k
Norbert Hilf Germany	16	1.3k 0.8×	1.0k 0.9×	467 0.7×	218 0.8×	234 1.1×	31	1.9k
Stephen J. Ullrich United States	18	848 0.5×	1.1k 0.9×	727 1.1×	246 0.9×	112 0.5×	25	2.2k
Robert W. Karr United States	32	3.0k 1.7×	874 0.8×	299 0.4×	392 1.4×	77 0.4×	84	4.3k
Fabrizio Poccia Italy	37	3.1k 1.8×	532 0.5×	677 1.0×	830 2.9×	111 0.5×	92	4.3k
Paola Fortugno Italy	18	443 0.3×	1.1k 1.0×	358 0.5×	176 0.6×	285 1.3×	42	1.8k
Bernard Maillère France	34	1.8k 1.0×	1.2k 1.0×	601 0.9×	437 1.5×	71 0.3×	141	3.7k
Guy Gammon United States	28	1.6k 0.9×	1.1k 1.0×	756 1.1×	139 0.5×	40 0.2×	64	3.4k
Zachary C. Hartman United States	27	908 0.5×	1.2k 1.1×	1.0k 1.5×	166 0.6×	64 0.3×	68	2.5k
Michael Heike Germany	19	542 0.3×	700 0.6×	451 0.7×	145 0.5×	185 0.9×	58	1.6k
Lawrence J. Wysocki United States	28	2.6k 1.5×	1.1k 1.0×	216 0.3×	191 0.7×	50 0.2×	60	3.5k

Countries citing papers authored by Harpreet Singh‐Jasuja

Since Specialization

Citations

This map shows the geographic impact of Harpreet Singh‐Jasuja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harpreet Singh‐Jasuja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harpreet Singh‐Jasuja more than expected).

Fields of papers citing papers by Harpreet Singh‐Jasuja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harpreet Singh‐Jasuja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harpreet Singh‐Jasuja. The network helps show where Harpreet Singh‐Jasuja may publish in the future.

Co-authorship network of co-authors of Harpreet Singh‐Jasuja

This figure shows the co-authorship network connecting the top 25 collaborators of Harpreet Singh‐Jasuja. A scholar is included among the top collaborators of Harpreet Singh‐Jasuja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harpreet Singh‐Jasuja. Harpreet Singh‐Jasuja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bunk, Sebastian, Martin Hofmann, Felix Unverdorben, et al.. (2019). Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER®) Molecules. Blood. 134(Supplement_1). 3368–3368. 7 indexed citations

Wick, Wolfgang, Pierre‐Yves Dietrich, Norbert Hilf, et al.. (2018). ATIM-20. GAPVAC-101 TRIAL OF A HIGHLY PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology. 20(suppl_6). vi5–vi5. 1 indexed citations

Rausch, Steffen, Cécile Gouttefangeas, Jörg Hennenlotter, et al.. (2017). Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases. European Urology Focus. 5(4). 604–607. 19 indexed citations

Rampling, R., Paul Mulholland, Allan James, et al.. (2016). A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research. 22(19). 4776–4785. 122 indexed citations

Halford, Sarah, R. Rampling, Allan James, et al.. (2014). Final Results from a Cancer Research Uk First in Man Phase I Trial of Ima950 (A Novel Multi Peptide Vaccine) Plus Gm-Csf in Patients with Newly Diagnosed Glioblastoma. Annals of Oncology. 25. iv364–iv364. 7 indexed citations

Pawlowski, Nina N., et al.. (2013). Abstract 3971: Impact of various first- and second-generation tyrosine-kinase inhibitors on frequency and functionality of immune cells.. Cancer Research. 73(8_Supplement). 3971–3971. 1 indexed citations

Bedke, Jens, et al.. (2013). Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy. World Journal of Urology. 32(1). 31–38. 25 indexed citations

Walter, Steffen, Toni Weinschenk, Carsten Reinhardt, & Harpreet Singh‐Jasuja. (2012). Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901. OncoImmunology. 2(1). e22246–e22246. 32 indexed citations

Staehler, Michael, P.Y. Dietrich, Timothy Eisen, et al.. (2007). A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC). Journal of Clinical Oncology. 25(18_suppl). 5098–5098. 5 indexed citations

10.

Decker, Patrice, et al.. (2005). Nucleosome, the Main Autoantigen in Systemic Lupus Erythematosus, Induces Direct Dendritic Cell Activation via a MyD88-Independent Pathway: Consequences on Inflammation. The Journal of Immunology. 174(6). 3326–3334. 91 indexed citations

11.

Bruder, Dunja, Alexander K. Nussbaum, Markus Schirle, et al.. (2005). Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O. International Immunology. 18(1). 89–100. 7 indexed citations

12.

Singh‐Jasuja, Harpreet, et al.. (2005). Glycoprotein 96–activated dendritic cells induce a CD8-biased T cell response. Cell Stress and Chaperones. 10(3). 221–221. 32 indexed citations

13.

Singh‐Jasuja, Harpreet, Niels Emmerich, & Hans‐Georg Rammensee. (2004). The T�bingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy. Cancer Immunology Immunotherapy. 53(3). 187–195. 101 indexed citations

14.

Radsak, Markus P., Norbert Hilf, Harpreet Singh‐Jasuja, et al.. (2003). The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. Blood. 101(7). 2810–2815. 54 indexed citations

15.

Hilf, Norbert, Harpreet Singh‐Jasuja, & Hansjörg Schild. (2002). The heat shock protein Gp96 links innate and specific immunity. International Journal of Hyperthermia. 18(6). 521–533. 18 indexed citations

16.

Vabulas, R. Martin, Norbert Hilf, Harpreet Singh‐Jasuja, et al.. (2002). The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway. Journal of Biological Chemistry. 277(23). 20847–20853. 378 indexed citations

17.

Welte, S., Christian Sinzger, Stefan Lutz, et al.. (2002). Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. European Journal of Immunology. 33(1). 194–203. 195 indexed citations

18.

Hilf, Norbert, et al.. (2002). Human platelets express heat shock protein receptors and regulate dendritic cell maturation. Blood. 99(10). 3676–3682. 62 indexed citations

19.

Singh‐Jasuja, Harpreet, Norbert Hilf, Hans Ulrich Scherer, et al.. (2000). The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells. Cell Stress and Chaperones. 5(5). 462–462. 63 indexed citations

20.

Singh‐Jasuja, Harpreet, Hans Ulrich Scherer, Norbert Hilf, et al.. (2000). The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. European Journal of Immunology. 30(8). 2211–2215. 292 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact